East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Citalopram Capsules, 30 mg. Aurobindo Pharma’s Citalopram Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Citalopram Capsules manufactured by Almatica Pharma, LLC .

Citalopram Capsules are indicated for:

• The treatment of Major Depressive Disorder (MDD) in adults.